Chronic obstructive pulmonary disease (COPD) is strongly associated with progressive airway limitation where the key mechanism is abnormal airway remodelling of bronchial mucosa maintained by complex crosstalk of tissue remodelling and regulatory factors. The aim of this study was to determine the appearance and local distribution of tissue remodelling factors in COPDaffected lung tissue and to compare the findings with the control group. In this study, lung tissue specimens were obtained from 27 patients with COPD and 49 control patients. Tissue samples were examined by routine hematoxylin and eosin staining. Remodelling and regulatory factors matrix metalloproteinase-2 (MMP-2), tissue inhibitor of metalloproteinase-2 (TIMP-2), transforming growth factor-β1 (TGF-β1), as well as heat shock protein-70 (Hsp-70) were detected by immunohistochemistry in airway mucosa. The numbers of positive structures were evaluated semiquantitatively. Non-parametrical statistical analysis was performed. Overall COPD-affected lung tissue presented chronic inflammation and tissue remodelling in routine histological analysis. Compared to the control group, statistically significant (P<0.05) difference was calculated between COPD affected lung tissue and control group with overall more immunoreactive cells containing MMP-2, TIMP-2 and TGF-β1 and less Hsp-70 immunoreactive bronchial epithelial cells, subepithelial connective tissue fibroblasts, bronchial smooth muscle cells and secretory cells of bronchial glands with more pronounced findings of TGF-β1, however, less Papers on Anthropology XXVI/2, 2017, pp. 157-167 COPD AFFECTED LUNG TISSUE REMODELLING DUE TO THE LOCAL DISTRIBUTION OF MMP-2, TIMP-2, TGF-β1 AND HSP-70 158 | Z. Vitenberga, M. Pilmane, A. Babjoniševa key role of these remodelling factors in COPD pathogenesis. Decrease of Hsp-70 proves increased cell damage in COPD-affected airway mucosa.
INTRODUCTION
Chronic obstructive pulmonary disease (COPD) is a chronic infl ammatory lung disease that causes obstructed airfl ow through the lung airways. In COPD, mostly the pathogenic triad of chronic infl ammation, altered and disrupted remodelling, as well as oxidative stress correspond to the cytopathology and histopathology [6] . Altered infl ammatory response, cell and tissue damage, also abnormal repair of cell and tissue injury confi rms defective remodelling of the extracellular matrix (ECM) in lung airways. ECM in airways is composed of matrix proteins, as well as molecular environment modifying molecules like matrix metalloproteinases (MMPs), growth and regulatory factors and signalling molecules [18] . Matrix metalloproteinase 2 (MMP-2) from the gelatinase family strongly aff ects the ECM components in tissue remodelling, as well as connective tissue cell migration and wound healing that might lead to fi brosis [14] . Tissue inhibitors of metalloproteinases (TIMPs) are acting as direct inhibi tors of MMPs; moreover, TIMPs like tissue inhibitor of metalloproteinase 2 (TIMP-2) promote cell growth and protect cells from apoptosis. TIMPs not only aff ect tissue remodelling, but also shape and organize appropriate ECM environment and architecture. Increased levels of TIMPs promote ECM accumu lation towards fi brosis, whereas the decrease of TIMPs enhances proteolysis in ECM. TIMPs regulate MMPs within ECM by inhibiting their maintenance [1, 6, 7] . Overall eff ective ECM remodelling in lung tissue is regulated as a dynamic balance between the proper cell and tissue renewal and, conversely, the tissue degradation. In COPD, airway remodelling occurs as a resistance response to the cigarette smoking induced damage to airway cells and tissues [16] . Tissue remodelling aspect of COPD pathogenesis in molecular level predominantly contributes by an imbalance of proteolytic and antipro teolytic mechanisms with pathological ECM degradation or controversially, ECM deposition [6] . Extensive production of ECM components with imbalance of MMPs and TIMPs to build remodelled tissue is evaluated as crucial in COPD pathogenesis with activated bronchial epithelium that further triggers subepithelial connective tissue to promote airway fi brosis with rapid diff erentiation of fi broblasts into myofi broblasts [9, 17] . Remodelling of central airways in COPD due to the increased deposition of ECM proteins, as well as an increase of smooth muscle cell area leads to airway obstruction initiating luminal narrowing [9] . Th e transforming growth factor β1 (TGF-β1) is the most abundant member of the transforming growth factor (TGF) family in lung tissue. TGF-β1 promotes the secretion and deposition of ECM proteins by airway fi broblasts and myofi broblasts [9, 11] . Secretion of TGF-β1 by injured epithelial cells induces airway epithelial wound repair and further subepithelial ECM remodelling [4] . 70-kDa heat shock protein (Hsp-70) is intracellularly located molecular chaperone with regulatory role of extracellular chemokine production infl uencing both normal innate immunity responses and infl ammatory signalling [5] . Synthesis of Hsp-70 is upregulated during diff erent stresses (physical or chemical stress), especially during oxidative stress, thus it maintains protective eff ects against cell and tissue damage universally in human tissue [13] . Reactive oxygen species (ROS) as oxidative stress stimuli promoted by cigarette smoking could mediate cell and tissue alterations, as well as cell senescence in COPD. ROS also interact with proteases and antiproteases then triggering the imbalance of both. Hsp-70 as oxidative stress biomarker therefore could contribute in COPD pathogenesis within oxidative injury [6] .
Although many molecular signalling pathways are studied in COPD pathogenesis, they eventually fail leading to abnormal and altered cell crosstalk, regulation and adaption. Th us, the aim of this study was to explore the appearance and local distribution of tissue remodelling and regulatory factors in COPDaff ected lung tissue.
MATERIALS AND METHODS
COPD-aff ected lung tissue specimens were obtained during fi brobronchoscopy from 27 patients aged from 53 to 85. Th e diagnosis of COPD was assessed by both clinical criteria and during bronchoscopy. Th e lung tissue material of the control group was obtained during autopsy from 49 relatively healthy study subjects aged from 9 to 95 years. Th e study was approved by the Ethical Committee of Pauls Stradiņš Clinical University Hospital (23 January 2013). Tissue sections (5 μm) were cut to proceed to routine histological staining with hematoxylin and eosin. All lung tissue specimens were examined by bright fi eld light microscopy. Tissue remodelling and regulatory markers were studied using the biotin-streptavidin immunohistochemistry (IHC) method. Primary antibodies of MMP-2 (R&D Systems, Germany), TIMP-2 (Santa Cruz Biotechnology, USA), TGF-β1 (Biorbyt, UK), and Hsp-70 (Invitrogen, Italy) were used in this study. Th e appearance and distribution of immunoreactive (positive) cells was evaluated semi-quantitatively [12] , counting the relative number of positive epithelial cells, mucosal fi broblasts, glandulocytes, bronchial smooth muscle cells and capillary endothelial cells. Th e following scale of semi-quantitative method was used, grading the positive cells seen in the visual fi eld at ×400 magnifi cation: 0 -no positive cells, 0/+ -occasional, + -few, +/++ -few to moderate number, ++ -moderate number, ++/+++ -moderate number to numerous, +++ -numerous, +++/++++ -numerous to abundance, ++++ -abundance of positive cells. To perform statistical analysis, nonparametric statistical methods -Mann-Whitney U test and Spearman's rank-order correlation -were used. All data were categorized in ordinal ranking as ordinal values, where the ranking system of nine ranks was applied from the value of 0 (no positive structures (0)), the value 0.5 (occasional positive cells (0/+)), et cetera to the value of 4.0 (abundance (++++)).
RESULTS
In routine histological analysis, COPD-aff ected lung tissue presented various degrees of chronic infl ammation and tissue remodelling. We evidenced goblet cell hyperplasia (Fig. 1A) , bronchial epithelial squamous metaplasia, subepithelial basement membrane thickening, airway fi brosis with thick connective tissue collagen bundles, bronchial gland hypertrophy and hyperplasia (Fig. 1B) , bronchial microvasculature remodelling, smooth muscle cell hyperplasia and hypertrophy, remarkable infl ammatory cell infi ltration in airway mucosa and submucosa, and glandular tissue.
Th e numbers of MMP-2 positive cells varied from no positive cells (0) in the connective tissue, bronchial glands, smooth muscles and in the endothelium to abundance (++++) of positive cells in the bronchial epithelium (Table 1) . Overall, the appearance of MMP-2 immunoreactive cells was evaluated as highest in the bronchial epithelium and connective tissue, however, we found fewer MMP-2 positive cells in the bronchial smooth muscle. Th e numbers of TIMP-2 immunoreactive cells were estimated ranging from no positive cells (0) in the bronchial glands reaching the maximum value of abundance (++++) of cells in the bronchial epithelium and from numerous to abundance (+++/++++) of TIMP-2-containing cells in the connective tissue and In all the statistical analyses, P values < 0.05 were considered statistically significant. "ns" -not statistically significant (P≥0.05).
"0" -no positive (0) structures seen in the visual field, "0. Compared to the control group, Mann-Whitney U-test showed a statistically signifi cant (P<0.05) diff erence between COPD-aff ected lung tissue and the control group with overall more immunoreactive cells in all the examined tissues of bronchial epithelium, subepithelial connective tissue, bronchial glands, small capillary endothelium and bronchial smooth muscle containing more MMP-2 (Fig. 1C, Fig. 1D ), TIMP-2 and TGF-β1 and fewer Hsp-70 (Fig.  1E, Fig. 1F ) immunoreactive cells. With large eff ect size r calculated (> 0.7) to specify Mann-Whitney U test results, COPD-aff ected lung tissue is more likely to evidence an increased number of MMP-2, TIMP-2 and TGF-β1 immunoreactive cells. Bronchial epithelial cells, subepithelial connective tissue fi broblasts, bronchial smooth muscle cells and endothelial cells indicated more pronounced fi ndings of TGF-β1, however, fewer Hsp-70 immunoreactive bronchial epithelial cells compared to the normal control group (Table 1) .
DISCUSSION
In COPD-aff ected lung tissue, MMP-2 immunoreactive cells were ranked higher in bronchial epithelium and subepithelial connective tissue (median values 3.0 and 2.0, respectively). Th ese fi ndings suggest COPD tissue is more likely to evidence an increase of MMP-2 in these compartments of the bronchial mucosa compared to the healthy control group. In COPD patients with the background of cigarette smoking, air-derived irritants might harm the epithelial tissue and initiate infl ammation with attracting immune cells and activating proteolytic environment with the predominance of collagenase MMP-2. Furthermore, degraded extracellular matrix (ECM) fragments might act as local chemokines and promote local infl ammation [2] . MMP-2 gene expression is induced by cigarette smoke in normal lung connective tissue fi broblasts [17] . Also in COPD-aff ected lung tissue, lung fi broblasts show induced MMP-2 protein expression, as well as increased MMP-2 gelatinase activity against ECM [10] . Immunoreactivity, protein expression, gelatinolytic activities of MMP-2 was markedly increased in epithelial cells, fi broblasts and endothelial cells in COPD suggesting up-regulation of MMP-2 [8] . Also, when compared to the control group, the medium eff ect size (0.5 < r < 0.7) was calculated for MMP-2 immunoreactive bronchial epithelial cell and connective tissue fi broblasts suggesting their increased role in COPD development.
Similarly to the fi ndings of MMP-2, we found more pronounced TIMP-2 appearance in bronchial epithelium and connective tissue; moreover, high numbers of immunoreactive TIMP-2 endothelial cells were also found (median values 3.0, 2.5 and 2.0, respectively). To maintain the stability of ECM environment, TIMP-2 directly inhibits MMP-2; therefore, the location of TIMP-2 is crucial. Aft er the release, both active form and pro-active form of MMPs are regulated by the activity of TIMPs [1] . In COPD, imbalance of proteases (MMPs) and antiproteases (TIMPs) induces structural changes in the form of pathological tissue repair and airway remodelling [17] . In our study, we might support this opinion of TIMP-2 predominance over MMP-2 with its regulatory role in airway remodelling. Moreover, these fi ndings might suggest the background of airway fi brosis that we estimated as ECM depositions with thick collagen fi bre bundles in our patients.
Compared to all other examined remodelling and regulatory factors, we counted more TGF-β1 immunoreactive cells in all the examined tissue compartments (median values were ranging from 2.0 to 3.0) of COPD-aff ected bronchial mucosa with more pronounced fi ndings in the bronchial epithelium. When stimulated with TGF-β1, airway basal epithelial cells might lead the whole bronchial epithelium to squamous metaplasia and goblet cell hyperplasia or contribute to airway fi brosis through epithelial to mesenchymal transition [15] . Th e background then of fi brosis in airways is master regulation of TGF-β1 with the consequences of pseudostratifi ed epithelial to mesenchymal transition, as well as fi broblast to myofi broblast and even smooth muscle cell to myofi broblast transition [9] . TGF-β1 release based on oxidant-mediated mechanisms confi rms the activating role of oxidative stress [3, 9] . In our study, the most pronounced site of TGF-β1 was exactly bronchial epithelium. Since the epithelium is aff ected by cigarette smoke fi rst, epithelial cells must tolerate oxidative injury with an increased release of regulatory molecules suggesting their protective role. Airway epithelium, activated smooth muscle, fi broblasts and myofi broblasts are important sources of TGF-β1, moreover, with a powerful eff ect on tissue remodelling [7] . TGF-β1 exerts a protective role by struggling to maintain lung tissue homeostasis in physiological conditions that are usually lost in COPD [3] .
In all the examined tissue compartments, we found fewer or similar numbers of Hsp-70 immunoreactive cells overall and compared to the control group. Th e examined cells were mostly negative (0) for Hsp-70 immunostaining, however, reaching only occasional (median value 0.5) numbers of bronchial epithelial cells that had the highest values in the COPD group. In the control tissue, the numbers of Hsp-70 immunoreactive cells were few to moderate (median value 1.5) in the bronchial epithelium and occasional (median value 0.5) in the bronchial connective tissue and bronchial glands. Although Hsp-70 maintains the protective role against cytotoxic damage and it is up-regulated under physical and chemical stress stimuli, abnormal Hsp-70 expression might occur if prolonged stress stimuli keep cellular and tissue stress response. When chronic cigarette smoking occurs, long-term oxidative stress might cause oxidative damage due to accumulation of oxidative products in airway tissue [13] . Adaption to chronic oxidative stress occurs through down-regulation of Hsp-70. Moreover, short-time exposure of cigarette smoke initiates an increased expression of Hsp-70. Conversely, long-term exposure caused dramatically decreased expression of Hsp-70, genotoxicity altogether with DNA damage, cell and tissue injury [19] .
In conclusion, the wide distribution and extensive appearance of MMP-2, TIMP-2, TGF-β1, and Hsp-70 proposes pronounced tissue damage and remodelling with the local regulatory patterns of increased TGF-β1. Increased numbers of MMP-2, TIMP-2 and TGF-β1 immunoreactive cells suggest the key role of these remodelling factors in COPD pathogenesis. Decrease of Hsp-70 proves its impaired function and increased cell damage in COPD aff ected lung tissue.
